Eikonoklastes Therapeutics, Inc. logo

Eikonoklastes Therapeutics, Inc.

https://www.eikonoklastes.com/

8 employees · est. 2019

VS
Octave logo

Octave

Your partner in precision care for multiple sclerosis (MS) and beyond.

88 employees · est. 2014 · Menlo Park, United States

Octave is the older company (2019 vs 2014); Octave is the larger of the two.

Side-by-Side Comparison

Eikonoklastes Therapeutics, Inc. Octave
Founded
2019 2014 older
Headquarters
Not tracked yet Menlo Park, United States
Employees
8 88 larger
Industry
Biopharma, Biotechnology, Life Sciences Biotechnology, Health Care
Funding Stage
Series A Grant
Total Funding
$5.98M $91.00M
Funding Rounds
2 6
Services
Not tracked yet Not tracked yet
Target Customers
Not tracked yet Not tracked yet
Taxonomy
Biopharmaceutical, Neurodegenerative Diseases, Gene Therapy, ALS, Lou Gehrig’s Disease, Nerve Disease, Muscle Degeneration, Neuromuscular Signaling, Rare Disease, Treatment Options, Accelerated Approvals, Neurotrophic Factor, Innovative Medicines, Disease-modifying Therapy Precision Medicine, Neurodegenerative Diseases, Multiple Sclerosis, Parkinson's Disease, MSDA Test, Blood Test, MRI Analytics, Clinical Care Program, Biological Data Analysis, Disease Management, Healthcare Innovation, Healthcare Collaboration, Healthcare Analytics, Patient Care
Website
eikonoklastes.com octavebio.com
Eikonoklastes Therapeutics, Inc. logo

About Eikonoklastes Therapeutics, Inc.

Eikonoklastes Therapeutics, Inc. is an early-stage biopharmaceutical company that is striving to revolutionize the treatment of neurodegenerative diseases. The company's groundbreaking gene therapy, which goes beyond the conventional approach of single defective gene replacement, aims to provide ext...

Octave logo

About Octave

Octave® Bioscience Inc. is a dynamic company offering a new approach to addressing the challenges of Multiple Sclerosis (MS) and other neurodegenerative diseases. Founded in 2014 and based in the United States, Octave is making significant strides in the Biotechnology and Health Care industries. The...

Be first to know when either one moves

Funding rounds, hiring surges, leadership changes and stack switches at Eikonoklastes Therapeutics, Inc. and Octave — tracked continuously, sent the day they land.

Watch both — free

Funding, hiring, leadership and stack changes at Eikonoklastes Therapeu... and Octave — by email.

Frequently Asked Questions

Eikonoklastes Therapeutics, Inc. — https://www.eikonoklastes.com/. Octave — Your partner in precision care for multiple sclerosis (MS) and beyond.. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Eikonoklastes Therapeutics, Inc. has raised $5.98M while Octave has raised $91.00M.
Eikonoklastes Therapeutics, Inc. and Octave operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Eikonoklastes Therapeutics, Inc. with someone else

Start typing a company name or domain.

Related Comparisons

One analytics cookie (Google Analytics). Cookie Policy